Piper Sandler reaffirmed its Overweight rating on DexCom (NASDAQ:DXCM) stock, maintaining a price target of $90.00. The firm's analysts highlighted several positive developments for the medical device ...
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Praxis Precision Medicines (PRAX – Research Report) today and set a price ...
Piper Sandler analyst Stephen Scouten maintained a Buy rating on Home Bancshares (HOMB – Research Report) today and set a price target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback